Article Details

MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of ...

Retrieved on: 2022-08-03 00:27:25

Tags for this article:

Click the tags to see associated articles and topics

MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of .... View article details on hiswai:

Excerpt

MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Small-Cell Lung Cancer (SCLC) - read this article along with ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up